HomeMost PopularThe Resilient Rise of AbbVie: A Closer Look at Their "S.A.F.E. 25"...

The Resilient Rise of AbbVie: A Closer Look at Their “S.A.F.E. 25” Dividend Stock Status

Daily Market Recaps (no fluff)

always free

The Unwavering Strength of AbbVie’s Dividend Potential

AbbVie Inc (ABBV) emerges as a shining star on the radar of dividend investors, securing a prestigious spot on the renowned Dividend Channel “S.A.F.E. 25” list. The company’s robust dividend statistics, highlighted by a robust 3.2% yield and an illustrious history of consistent dividend growth spanning over two decades, serve as a testament to their unwavering commitment to shareholder value.

Looking Beyond the Numbers: AbbVie’s Market Presence

In the intricate web of exchange-traded funds (ETFs), AbbVie Inc is a key member of the iShares S&P 1500 Index ETF (ITOT), while also serving as an underlying holding representing 1.73% of the SPDR S&P Dividend ETF (SDY). With stocks worth a staggering $366,894,950 under its umbrella, AbbVie shines brightly in the competitive market landscape.

Decoding the AbbVie Advantage: The “S.A.F.E. 25” Criteria

The “Dividend Channel S.A.F.E. 25” accolade bestowed upon AbbVie Inc is not a mere fluke. It is a result of their unwavering commitment to excellence across four key metrics: S. Solid return with a hefty yield and strong DividendRank characteristics; A. Accelerating amount manifested through consistent dividend increases; F. Flawless history underscored by a track record devoid of missed or lowered dividends; E. Enduring legacy of at least two decades of consistent dividend payments.

AbbVie’s Dividend Prowess: A Charted Journey

The annualized dividend of $6.2/share paid by AbbVie Inc in quarterly installments underscores their commitment to rewarding shareholders. With a recent dividend ex-date on 10/15/2024, AbbVie’s long-term dividend history, encapsulated in a chart, stands as a testament to their unwavering dedication to creating long-term value.

AbbVie in Context: Navigating the Pharmaceuticals Sector

In the realm of Drugs & Pharmaceuticals, AbbVie Inc stands shoulder to shoulder with industry giants like Novo-Nordisk AS (NVO) and Eli Lilly (LLY), showcasing their prowess in a competitive landscape defined by innovation and resilience.

nslideshow Top 25 S.A.F.E. Dividend Stocks Increasing Payments For Decades »

Also see:

• BRY Next Dividend Date
• APOG YTD Return
• TECH MACD

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Do you want a daily market summary with no fluff?

Simple Straightforward Daily Stock Market Recaps Sent for free,every single trading day: Read Now

Explore More

Simple Straightforward Daily Stock Market Recaps

Get institutional-level analysis to take your trading to the next level, sign up for free and become apart of the community.